Irinotecan Intravenous and Omalizumab Subcutaneous
Determining the interaction of Irinotecan Intravenous and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: irinotecan
Brand name: Camptosar
Synonyms: Irinotecan, Irinotecan (Conventional)
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Irinotecan Intravenous-Ombitasvir, Paritaprevir, and Ritonavir
- Irinotecan Intravenous-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Irinotecan Intravenous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Irinotecan Intravenous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Irinotecan Intravenous-Omeclamox-Pak
- Irinotecan Intravenous-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Irinotecan liposomal
- Omalizumab Subcutaneous-Irinotecan liposome Intravenous
- Omalizumab Subcutaneous-Iron 100/C
- Omalizumab Subcutaneous-Iron 21/7
- Omalizumab Subcutaneous-Iron and Docusate
- Omalizumab Subcutaneous-Iron and Folic Acid